Left Atrial Appendage Exclusion (LAAE) is recommended during heart surgery by The Society of Thoracic Surgeons, American College of Cardiology, and the American Heart Association
Cardiothoracic surgeon Dr. Drotar and EP Dr. Atteya from @CBMCNJ joined forces to treat their first LSPAF patient with Hybrid AF™ Therapy.
Together, they exemplify a dual approach yielding better outcomes. Discover the innovative strategy reshaping LSPAF treatment:… https://t.co/G2e1DJu6CB
Cardiothoracic surgeon Dr. Drotar and EP Dr. Atteya from @CBMCNJ joined forces to treat their first LSPAF patient with Hybrid AF™ Therapy.
Together, they exemplify a dual approach yielding better outcomes. Discover the innovative strategy reshaping LSPAF treatment:… https://t.co/G2e1DJu6CB
With features like dynamic closing force, tissue compression, & epicardial exclusion, AtriClip® devices are the most widely implanted LAAM devices worldwide.
Learn more about the benefits of #LAAE by stopping by booth #905 at AATS or visit: https://t.co/iMwiR7oII8#CardioTwitter
With features like dynamic closing force, tissue compression, & epicardial exclusion, AtriClip® devices are the most widely implanted LAAM devices worldwide.
Learn more about the benefits of #LAAE by stopping by booth #905 at AATS or visit: https://t.co/iMwiR7oII8#CardioTwitter
Heart failure is the leading cause of death in Afib patients.
However, cardiac surgeons have the opportunity during valve or bypass surgery to halt the progression of HF symptoms and restore sinus rhythm. (1/2)
Heart failure is the leading cause of death in Afib patients.
However, cardiac surgeons have the opportunity during valve or bypass surgery to halt the progression of HF symptoms and restore sinus rhythm. (1/2)
The CEASE-AF randomized controlled trial demonstrated long-term durability of Hybrid ablation through 24 months of follow-up and ~33% absolute improvement in freedom from atrial arrhythmias* in patients with LSPAF.**
Learn more: https://t.co/210NYNg3kE
*Freedom from atrial… https://t.co/WRMb2ysxp4
The CEASE-AF randomized controlled trial demonstrated long-term durability of Hybrid ablation through 24 months of follow-up and ~33% absolute improvement in freedom from atrial arrhythmias* in patients with LSPAF.**
Learn more: https://t.co/210NYNg3kE
*Freedom from atrial… https://t.co/WRMb2ysxp4
Our passion for helping others extends into our communities through our employees’ drive and commitment to giving back.
From working with organizations like the American Heart Association, local non-profits and food drives, we provide two days of Volunteer Time Off each year to employees to support local causes.
#ThisIsAtriCure#NationalVolunteerWeek
Our passion for helping others extends into our communities through our employees’ drive and commitment to giving back.
From working with organizations like the American Heart Association, local non-profits and food drives, we provide two days of Volunteer Time Off each year to employees to support local causes.
#ThisIsAtriCure#NationalVolunteerWeek
What is a sinus node sparing hybrid ablation? It...
- Is a minimally invasive procedure
- Offers direct visualization of key heart structures
- Can reduce damage to adjacent tissues like the esophagus or phrenic nerve
- Allows for sinus node identification via endocardial mapping and precise epicardial ablation
Learn more about this new procedure being evaluated in the HEAL-IST clinical trial at www.heal-ist.com.
What is a sinus node sparing hybrid ablation? It...
- Is a minimally invasive procedure
- Offers direct visualization of key heart structures
- Can reduce damage to adjacent tissues like the esophagus or phrenic nerve
- Allows for sinus node identification via endocardial mapping and precise epicardial ablation
Learn more about this new procedure being evaluated in the HEAL-IST clinical trial at www.heal-ist.com.
Pectus patients and families face tough decisions regarding the Nuss procedure's post-op pain and recovery process. With Cryo Nerve Block, we're reshaping the conversation.
Discover why Dr. Mark Walton integrated #CryoNB into his practice and learn how it’s putting patients like Brandon at ease:
https://okt.to/LilmNO
Hamilton Health Sciences
Pectus patients and families face tough decisions regarding the Nuss procedure's post-op pain and recovery process. With Cryo Nerve Block, we're reshaping the conversation.
Discover why Dr. Mark Walton integrated #CryoNB into his practice and learn how it’s putting patients like Brandon at ease:
https://okt.to/LilmNO
Hamilton Health Sciences
We’ve reached a milestone in our LeAAPS™ Trial – more than 2,000 patients are now enrolled! As the largest randomized clinical trial in cardiac surgery history, the trial is set to evaluate whether LAA exclusion can reduce stroke in cardiac surgery patients with no prior history of Afib.
Want to learn more about the groundbreaking study? Visit: https://okt.to/viYPjO
#ClinicalTrial#Stroke
We’ve reached a milestone in our LeAAPS™ Trial – more than 2,000 patients are now enrolled! As the largest randomized clinical trial in cardiac surgery history, the trial is set to evaluate whether LAA exclusion can reduce stroke in cardiac surgery patients with no prior history of Afib.
Want to learn more about the groundbreaking study? Visit: https://okt.to/viYPjO
#ClinicalTrial#Stroke
Cardiothoracic Surgeon Dr. Persida S. Drotar and Cardiac Electrophysiologist Dr. Gourg (George) Atteya at Cooperman Barnabas Medical Center joined forces to treat their first long-standing persistent Afib patient with Hybrid AF™ Therapy.
Together, they exemplify a dual approach yielding better outcomes. Discover how this innovative strategy is reshaping Advanced Afib treatment efficacy: https://okt.to/eRY6Bh#HybridAFTherapy#Cardiac#CardiacSurgery#Epeeps
Cardiothoracic Surgeon Dr. Persida S. Drotar and Cardiac Electrophysiologist Dr. Gourg (George) Atteya at Cooperman Barnabas Medical Center joined forces to treat their first long-standing persistent Afib patient with Hybrid AF™ Therapy.
Together, they exemplify a dual approach yielding better outcomes. Discover how this innovative strategy is reshaping Advanced Afib treatment efficacy: https://okt.to/eRY6Bh#HybridAFTherapy#Cardiac#CardiacSurgery#Epeeps
With features like dynamic closing force, tissue compression, and epicardial exclusion, AtriClip® devices are the most widely implanted LAAM devices worldwide.
Come see AtriClip in-person and in action this weekend at AATS at booth #905.
Learn more about the benefits of LAA exclusion at: https://okt.to/QcxBnJ#AtriClip#LAAE#Cardiac
With features like dynamic closing force, tissue compression, and epicardial exclusion, AtriClip® devices are the most widely implanted LAAM devices worldwide.
Come see AtriClip in-person and in action this weekend at AATS at booth #905.
Learn more about the benefits of LAA exclusion at: https://okt.to/QcxBnJ#AtriClip#LAAE#Cardiac
Heart Failure (HF) is the leading cause of death in Afib patients.
However, cardiac surgeons have the opportunity during valve or bypass surgery to halt the progression of HF symptoms and restore sinus rhythm.
Treating Afib can improve the quality of life for patients after surgery and improve life expectancy.
Visit https://okt.to/gE8MbI to learn more.
#Afib#HeartFailure#Cardiac
Heart Failure (HF) is the leading cause of death in Afib patients.
However, cardiac surgeons have the opportunity during valve or bypass surgery to halt the progression of HF symptoms and restore sinus rhythm.
Treating Afib can improve the quality of life for patients after surgery and improve life expectancy.
Visit https://okt.to/gE8MbI to learn more.
#Afib#HeartFailure#Cardiac
The CEASE-AF randomized-controlled trial demonstrated long-term durability of Hybrid ablation through 24 months of follow-up and ~33% absolute improvement in freedom from atrial arrhythmias* in patients with long-standing persistent Afib.**
Learn more about the CEASE AF Trial: https://okt.to/uMrQBg
*Freedom from atrial arrhythmias (atrial fibrillation, atrial flutter, atrial tachycardia) off anti-arrhythmic drugs (AADs) except previously failed AADs at doses not exceeding those previously failed
**Persistent atrial fibrillation with enlarged left atrium and longstanding persistent Afib
#Cardiac#CardiacSurgery#Epeeps#ClinicalTrial
The CEASE-AF randomized-controlled trial demonstrated long-term durability of Hybrid ablation through 24 months of follow-up and ~33% absolute improvement in freedom from atrial arrhythmias* in patients with long-standing persistent Afib.**
Learn more about the CEASE AF Trial: https://okt.to/uMrQBg
*Freedom from atrial arrhythmias (atrial fibrillation, atrial flutter, atrial tachycardia) off anti-arrhythmic drugs (AADs) except previously failed AADs at doses not exceeding those previously failed
**Persistent atrial fibrillation with enlarged left atrium and longstanding persistent Afib
#Cardiac#CardiacSurgery#Epeeps#ClinicalTrial
social media channels to keep updated on the latest at AtriCure.
Blake's Pectus Excavatum Journey: 2 Months Post-Op
Duration: 2:31
Blake's Pectus Excavatum Journey: Surgery
Duration: 2:49
Blake's Pectus Excavatum Journey: 1 Week Pre-Op
Duration: 3:41
Blake's Pectus Excavatum Journey: 1 Month Pre-Op
Duration: 2:58